Evaluation of Maculopathy in Patients Using Hydroxychloroquine

Ugurlu A., Aslanova M., Cebeci Z., Mercul N. K.

Turkish journal of ophthalmology, vol.49, no.3, pp.149-153, 2019 (Scopus) identifier identifier identifier


Objectives: To determine length of hydroxychloroquine use and cumulative dose and evaluate the ocular effects by 10-2 central visual field test, microperimetry (MP), color fundus photography, optical coherence tomography (OCT), and fundus autofluorescence (FAF) in hydroxychloroquine users.